Piper Sandler maintains overweight on Edwards Lifesciences (EW) ahead of PARTNER 3 7-year results
Edwards Lifesciences Corporation (NYSE:EW) is among the The best medical device stocks to invest in.. Piper Sandler maintained her Overweight rating and $90 price target for Edwards Lifesciences Corporation (NYSE:EW) on October 7, ahead of expected 7-year findings from Edwards’ PARTNER 3 study, which will be presented on October 27 at the Transcatheter Cardiovascular Therapeutics…